| Chemicals Industry | Materials Sector | Dr. Xiucai Liu CEO | SSE Exchange | CNE100004447 ISIN |
| CN Country | 1,803 Employees | 29 Jul 2026 Last Dividend | 20 Jul 2022 Last Split | - IPO Date |
Cathay Biotech Inc. is a pioneering bio-manufacturing technology company that methodically investigates, develops, produces, and markets bio-based materials on a global scale. Established in 2000 and with its headquarters in Shanghai, China, the company focuses on enhancing sustainability across a variety of industries. By implementing cutting-edge biotechnological processes, Cathay Biotech Inc. contributes to the evolution of green manufacturing solutions, making it a significant player in both the Chinese and international markets for bio-based materials.
Applications: Used in the production of nylons, plastics, lubricants, adhesives, and powder coatings. By opting for these bio-based diacids, industries can reduce their carbon footprint and enhance the biodegradability of their products.
Applications: Widely used in the automotive, electrical, and electronics sectors, as well as in consumer goods like sportswear and other textiles, providing durability, strength, and a lower environmental impact.
Applications: Its application spans across the production of high-resilience textiles, automotive parts, and various high-strength, lightweight composite materials, aligning with sustainable development goals in material engineering.